ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
OncoSec Appoints Brian Leuthner as Interim CEO firstwordpharma
June 25, 2021OncoSec Medical Incorporated (NASDAQ:ONCS) today announced that Daniel O'Connor has resigned and that Brian Leuthner, formerly Chief Operating Officer, has been appointed Interim Chief Executive Officer, effective June 25, 2021.
Pharma Sources Insight January 2025
